Botulinum Toxin Market Research Report 2024-2030 By Players, Regions, Types & Applications
Botulinum Toxin Industry Overview
The
global botulinum toxin market size was valued at USD 11.1 billion in 2023 and
is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2024
to 2030. Botulinum toxin is a protein and neurotoxin produced by the bacterium
clostridium botulinum. The toxin is a selective blocker of acetylcholine
released from nerves, which blocks neural transmission from the nerves when
injected into muscle. Botulinum toxin is one of the most exceptional substances
encountered in medicine and science. The adoption of botulinum toxin in
cosmetology has grown rapidly over the decade, and at present it is one of the
most common and widely performed aesthetic procedures in the world. The
increasing concern for aesthetic features in developed and developing regions
has led to an increase in the number of cosmetic procedures.
Gather more insights about the market drivers, restrains and
growth of the Botulinum
Toxin Market
The
availability of a variety of botulinum toxin products such as botox, xeomin,
dysport, and others will accelerate the market growth. The increasing usage of
botulinum toxin injection in several aesthetic procedures including the
treatment of glabellar lines, chemical browlift, forehead lines, and others is
expected to boost the botulinum toxin industry growth over the coming years.
Presently, a few products of botulinum toxin - Type-A and only one product of
Type-B (Myobloc) are commercially available in the market.
However,
rising investment in R&D programs by major manufactures to explore the
therapeutic use of botulinum toxin is building opportunities for the expansion
of its therapeutic application area in the near future. A shift from invasive
to minimally invasive procedures is expected to fuel the market growth over the
forecast period. For instance, according to ISAPS, 17,598,888 noninvasive
procedures were performed globally in 2021, out of which 5,355,604 were
performed in the U.S. A large number of people are opting for permanent
procedures, such as fillers, fat grafting, and lip advancement.
Minimally
invasive procedures offer advantages such as smaller incisions, shorter
hospital stays, quick outpatient services, rapid wound healing, lesser pain,
and lower risk of complications than invasive surgeries. Thus, the demand for
botulinum toxin is expected to increase over the forecast period. Moreover,
many dermatologists believe that COVID-19 may act as a springboard that will
drastically increase patient footfall post-pandemic.
According
to a survey conducted on 1,000 American women in 2020 by American Society of
Plastic Surgeons, 11% of participants indicated that they are more inclined to
opt for minimally invasive procedures post-pandemic than pre-COVID-19. Even
during the pandemic, Botox and soft tissue fillers remained the most popular
minimally invasive procedures in the U.S.
Browse through Grand View Research's Medical Devices Industry
Research Reports.
•
The global bronchoscopes
market size was valued at USD 1.14 billion in 2023 and is projected
to grow at a CAGR of 11.4% from 2024 to 2030. The rising incidences of
respiratory disorders and growing awareness about early diagnosis are driving
demand for bronchoscopes.
•
The global western
blotting market size was valued at USD 986.2 million in
2023 and is projected to grow at a CAGR of 6.1% from 2024 to 2030. The rising
rate of brain disorders, research initiatives in the biotech and pharma
sectors, and funding by the pharmaceutical and biotechnology agencies drive
market growth.
Botulinum Toxin Market Segmentation
Grand
View Research has segmented the global botulinum toxin market report based on
product type, application, end-use, and region:
Botulinum Toxin Product Type Outlook (Revenue, USD Billion, 2018 -
2030)
• Type A
o Botox
o Dysport
o Xeomin
o Others
• Type B
Botulinum Toxin Application Outlook (Revenue, USD Billion, 2018 -
2030)
• Therapeutic
o Chronic Migraine
o Overactive Bladder
o Cervical Dystonia
o Spasticity
o Others
• Aesthetic
o Glabellar Lines
o Crow’s Feet
o Forehead Lines
o Others
Botulinum Toxin End-use Outlook (Revenue, USD Billion, 2018 -
2030)
• Hospitals
• Dermatology Clinics
• Cosmetic Centers and Medspas
Botulinum Toxin Regional Outlook (Revenue, USD Billion, 2018 -
2030)
• North America
o US
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o India
o Japan
o China
o South Korea
o Australia
o Thailand
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait
Order
a free sample PDF of the Botulinum Toxin
Market Intelligence Study, published by Grand View Research.
Key Companies profiled:
• Ipsen Group
• Allergen, Inc.
• Metabiologics
• Merz Pharma
• US Worldmeds
• Evolus
• Galderma
• Lanzhou Institute of Biological Products
Comments
Post a Comment